deltatrials
Recruiting INTERVENTIONAL NCT03544489

Effectiveness of Exercise After an ICD (E-ICD)

Clinical Effectiveness of Exercise After an ICD (E-ICD)

Sponsor: University of Washington

Interventions E-ICD Intervention
Updated 8 times since 2018 Last updated: Apr 21, 2026 Started: May 1, 2025 Primary completion: Jun 30, 2029 Completion: Jun 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Heart Arrest and Implantable Defibrillator User, this trial is actively recruiting participants. The trial is conducted by University of Washington and has accumulated 8 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Study Description(click to expand)

The goal of this study is to test the effectiveness and describe implementation of a home based exercise intervention for persons with an implantable cardioverter defibrillator (ICD). This study is based on the NIH stage model of behavioral interventions (stage III effectiveness) that aligns with the strategic mission of the NHLBI, to optimize clinical and implementation research to improve health and reduce disease (Obj #6). The study intervention is based on the protocol and monitoring components that were developed in prior RCTs and a pilot study conducted by our team. From these studies, we created a home based exercise program called Exercise-ICD (E-ICD) for testing in a broader range of ICD patients, that assists individuals to start and monitor exercise safely after an ICD. An randomized two group (E-ICD vs. usual care) pragmatic effectiveness mixed-methods study is proposed, to determine the effectiveness of the E-ICD intervention and describe implementation by cardiac rehabilitation (CR) clinical staff. Two hundred ten (N=210) patients in 3 local study sites (70/site) in the greater Seattle, WA area will participate. E-ICD is guided by the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) model. The E-ICD intervention consists of 12 weeks of home walking exercise using exercise prescriptions and protocols validated in...

The goal of this study is to test the effectiveness and describe implementation of a home based exercise intervention for persons with an implantable cardioverter defibrillator (ICD). This study is based on the NIH stage model of behavioral interventions (stage III effectiveness) that aligns with the strategic mission of the NHLBI, to optimize clinical and implementation research to improve health and reduce disease (Obj #6). The study intervention is based on the protocol and monitoring components that were developed in prior RCTs and a pilot study conducted by our team. From these studies, we created a home based exercise program called Exercise-ICD (E-ICD) for testing in a broader range of ICD patients, that assists individuals to start and monitor exercise safely after an ICD. An randomized two group (E-ICD vs. usual care) pragmatic effectiveness mixed-methods study is proposed, to determine the effectiveness of the E-ICD intervention and describe implementation by cardiac rehabilitation (CR) clinical staff. Two hundred ten (N=210) patients in 3 local study sites (70/site) in the greater Seattle, WA area will participate. E-ICD is guided by the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) model. The E-ICD intervention consists of 12 weeks of home walking exercise using exercise prescriptions and protocols validated in our previous work. The primary effectiveness outcome is patient physical activity (steps/day) after the E-ICD intervention at 3 months. We will determine the number of patients who reach the public health walking goal of moderate level exercise of 150 minutes/week at the end of the study. Measures will be taken at baseline, after the intervention at 3 months, and at 6 and 12 months to determine maintenance. The specific aims are to: 1) Test the hypothesis that participants randomized to E-ICD vs. usual care (UC) will demonstrate increased physical activity (minutes walked/week) \[primary outcome\], health related quality of life, gait speed, mobility, exercise self-efficacy; and reduced ICD shock anxiety and depression at 3 months (E-ICD Effectiveness), 2) Assess longer term effects of E-ICD on participant and health care system Maintenance, captured by 1) participant retention, satisfaction, and adherence at 12 months (total minutes/week), and 2) clinician and institutional intent to sustain use of the E-ICD intervention after the study, and 3) Evaluate the reach, adoption, and implementation of E-ICD by CR clinical staff. Reach will be assessed by the diverse patient participation rate, representativeness, and reasons for non-interest. Adoption is the participation rate and representativeness of the settings and staff who participate, and factors related to adoption. Implementation will be assessed by delivery fidelity of E-ICD and workflow adaptations, implementation costs, and consistency of delivery across settings.

Status Flow

~Jul 2018 – ~Jan 2021 · 30 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Oct 2023 · 33 months · monthly snapshotUnknown Status~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~May 2025 · 8 months · monthly snapshotNot Yet Recruiting~May 2025 – ~Aug 2025 · 3 months · monthly snapshotNot Yet Recruiting~Aug 2025 – ~Apr 2026 · 9 months · monthly snapshotRecruitingApr 28, 2026 – present · 3 months · daily APIRecruiting

Change History

8 versions recorded
  1. Apr 28, 2026 — Present [daily]

    Recruiting

    Phase: PHASE2/PHASE3None

  2. Aug 2025 — Apr 2026 [monthly]

    Recruiting PHASE2/PHASE3

    Status: Not Yet RecruitingRecruiting

  3. May 2025 — Aug 2025 [monthly]

    Not Yet Recruiting PHASE2/PHASE3

  4. Sep 2024 — May 2025 [monthly]

    Not Yet Recruiting PHASE2/PHASE3

    Status: CompletedNot Yet Recruiting · Phase: NAPHASE2/PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Completed NA

Show 3 earlier versions
  1. Oct 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown StatusCompleted · Phase: PHASE2NA

  2. Jan 2021 — Oct 2023 [monthly]

    Unknown Status PHASE2

    Status: Not Yet RecruitingUnknown Status

  3. Jul 2018 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

This study will test an exercise intervention (E-ICD) following an implantable cardioverter defibrillator.

Contact Information

Sponsor contact:
  • University of Washington
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations